• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-
-

2010 Warning Letters

Recently Posted | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

Warning Letters issued in 2010

 

* Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

* N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

Read more about warning and close-out letters

Posted on May 18, 2010

Letter Issue Date Company Name Issuing Office Subject Close Out Date
May 10, 2010 Dolce, L.L.C. Cincinnati District Office Seafood HACCP/Insanitary Conditions/Adulterated Not Issued *
May 10, 2010 Len-acres Seattle District Office Illegal Drug Residue Not Issued *
May 10, 2010 Braintree Laboratories Inc New England District Office CGMP For Manfacturing, Processing, Packing, Storage & Holding/Adulterated April 27, 2011
May 10, 2010 Willamette Shelling Inc Seattle District Office CGMP Regulation For Food/Adulterated Not Issued *
May 10, 2010 Aurora Ridge Dairy, LLC New York District Office Illegal Drug Residue Not Issued *
May 10, 2010 Service Smoked Fish Corp New York District Office Seafood HACCP/CGMP for Foods/Adulterated Not Issued *
May 10, 2010 Midstate Veterinary Services, PLLC New York District Office Illegal Drug Residue Not Issued *
May 07, 2010 Medtronic Navigation, Inc Denver District Office Medical Device/Lacks Premarket Approval/Adulterated/Misbranded Not Issued *
May 06, 2010 C.V. Foods Corporation, DBA Yo Lily Cheesecake Co. Los Angeles District Office CGMP Requirement for Food Manufacturing/Adulterated Not Issued *
May 03, 2010 Trilliant Surgical, LTD Dallas District Office CGMP/QSR/Medical Devices/Adulterated/Misbranded Not Issued *


 

Contact FDA

301-796-8490
FDA's Office of Critical Path Programs
-
-
-